These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7447217)

  • 61. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease.
    Kampouraki E; Kamali F
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):789-797. PubMed ID: 28635328
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A practical approach to minimize the interaction of dietary vitamin K with warfarin.
    Chang CH; Wang YW; Yeh Liu PY; Kao Yang YH
    J Clin Pharm Ther; 2014 Feb; 39(1):56-60. PubMed ID: 24383939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Avoidance of Vitamin K-Rich Foods Is Common among Warfarin Users and Translates into Lower Usual Vitamin K Intakes.
    Leblanc C; Dubé MP; Presse N; Dumas S; Nguyen M; Rouleau-Mailloux É; Perreault S; Ferland G
    J Acad Nutr Diet; 2016 Jun; 116(6):1000-7. PubMed ID: 26922378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows.
    Vermeer C; Soute BA; De Metz M; Hemker HC
    Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K.
    Whitlock RP; Crowther MA; Warkentin TE; Blackall MH; Farrokhyar F; Teoh KH
    Ann Thorac Surg; 2007 Jul; 84(1):103-8. PubMed ID: 17588394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin.
    Reaves AB; Clarke CJ; Tillman EM
    Ann Pharmacother; 2013 Jun; 47(6):e28. PubMed ID: 23719786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vitamin K and coumarin drug interrelationships in man.
    Udall JA
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):627-31. PubMed ID: 4962736
    [No Abstract]   [Full Text] [Related]  

  • 68. Coumadin resistance and the vitamin supplement "Noni".
    Carr ME; Klotz J; Bergeron M
    Am J Hematol; 2004 Sep; 77(1):103. PubMed ID: 15307118
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparison of different warfarin reversal protocols on surgical delay and complication rate in hip fracture patients.
    Leonidou A; Rallan R; Cox N; Pagkalos J; Luscombe J
    J Orthop Surg (Hong Kong); 2013 Aug; 21(2):142-5. PubMed ID: 24014771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
    Bern M
    JPEN J Parenter Enteral Nutr; 2004; 28(6):388-98. PubMed ID: 15568285
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Changed warfarin tolerance].
    Johannessen H
    Tidsskr Nor Laegeforen; 1973 Jun; 93(16):1236-9. PubMed ID: 4584765
    [No Abstract]   [Full Text] [Related]  

  • 72. Urgent warfarin reversal: know your options.
    Pendergrast J
    Can J Anaesth; 2010 May; 57(5):395-401. PubMed ID: 20177848
    [No Abstract]   [Full Text] [Related]  

  • 73. Efficacy of warfarin reversal in orthopedic trauma surgery patients.
    Tharmarajah P; Pusey J; Keeling D; Willett K
    J Orthop Trauma; 2007 Jan; 21(1):26-30. PubMed ID: 17211265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The vitamin K-dependent carboxylation system in human osteosarcoma U2-OS cells. Antidotal effect of vitamin K1 and a novel mechanism for the action of warfarin.
    Wallin R; Rossi F; Loeser R; Key LL
    Biochem J; 1990 Jul; 269(2):459-64. PubMed ID: 2386486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.
    Boonyawat K; Wang L; Lazo-Langner A; Kovacs MJ; Yeo E; Schnurr T; Schulman S; Crowther MA
    Thromb Haemost; 2016 Aug; 116(3):480-5. PubMed ID: 27346552
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cautions on the use of vitamin K and enteral preparations.
    Kutsop JJ
    Am Pharm; 1983 Oct; NS23(10):16-7. PubMed ID: 6637790
    [No Abstract]   [Full Text] [Related]  

  • 78. Important drug-nutrient interactions in the elderly.
    Thomas JA; Burns RA
    Drugs Aging; 1998 Sep; 13(3):199-209. PubMed ID: 9789724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High clearance of (S)-warfarin in a warfarin-resistant subject.
    Hallak HO; Wedlund PJ; Modi MW; Patel IH; Lewis GL; Woodruff B; Trowbridge AA
    Br J Clin Pharmacol; 1993 Mar; 35(3):327-30. PubMed ID: 8471414
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enteral feeds may antagonise warfarin.
    Watson AJ; Pegg M; Green JR
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):557. PubMed ID: 6421377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.